Sally Johnson

Sally Johnson is the Chief People Officer at Ribon Therapeutics. Sally has previous experience as the Global Lead of People Engagement & Operations at Novartis Institutes for BioMedical Research and as a Senior HR Consultant/HR Business Partner at Mercer. At Mercer, they were responsible for supporting multiple operations and functional departments with a focus on talent management, leadership/management development and employee relations. In their role at Novartis, they were responsible for making recommendations for HR systems and process changes to suit changing business requirements.

Sally Johnson has a BA (Hons) in French from the University of Liverpool, and has also studied at HayGroup.

Their manager is Prakash Raman, President & CEO. They work with Kevin Kuntz - Chief Drug Development Officer, Heike Keilhack - Chief Scientific Officer, and Gary Sutton - Chief Business Officer.